Spasticity Treatment During COVID-19 Pandemic: Clinical Recommendations (original) (raw)

Clinical Features of Spasticity and Principles of Treatment

Alexander Dromerick

Clinical Evaluation and Management of Spasticity, 2001

View PDFchevron_right

Chronic intrathecal baclofen administration for control of severe spasticity

John Ulatowski

Journal of Neurosurgery, 1990

View PDFchevron_right

Long-term modification of spasticity

Anthony Ward

Journal of Rehabilitation Medicine, 2003

View PDFchevron_right

Rehabilitation Medicine Management of Spasticity

seyed mansoor rayegani

2020

View PDFchevron_right

Quantitative assessment of intrathecally administered baclofen in spasticity

Christine Detrembleur

Archives of Physical Medicine and Rehabilitation, 2000

View PDFchevron_right

Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study

Bengt Linderoth

Journal of Neurology, Neurosurgery & Psychiatry, 1989

View PDFchevron_right

Long-term modification of spasticity 61

Anthony Ward

View PDFchevron_right

Practical Guidance for Outpatient Spasticity Management During the Coronavirus (COVID-19) Pandemic: Canadian Spasticity COVID-19 Task Force

Karen Ethans

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

View PDFchevron_right

Adult Spasticity International Registry Study: methodology and baseline patient, healthcare provider, and caregiver characteristics

Joan Largent

Journal of Rehabilitation Medicine

View PDFchevron_right

Continuous intrathecal baclofen delivery in severely disabling spasticity

M. Güney Şenol, Selim Akarsu, Emre Zorlu

2018

View PDFchevron_right

Spasticity and its management

Barry Rawicki

Current Therapeutics, 2001

View PDFchevron_right

The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database

Sam Eldabe, Rui Duarte

BMJ open, 2015

View PDFchevron_right

Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy

Charles Law

Archives of Physical Medicine and Rehabilitation, 2001

View PDFchevron_right

An international survey of patients living with spasticity

Jovita Balcaitiene

Disability and rehabilitation, 2016

View PDFchevron_right

Use of Intrathecal Baclofen for Treatment of Severe Spasticity in Selected Patients With Motor Neuron Disease

Nicholas Boulis

Neurorehabilitation and Neural Repair, 2013

View PDFchevron_right

Drug treatments for spasticity

M. Rousseaux

Annals of Physical and Rehabilitation Medicine, 2009

View PDFchevron_right

Spasticity: Non-pharmacological Rehabilitation Interventions

Deborah Backus

2019

View PDFchevron_right

Clinical Understanding of Spasticity: Implications for Practice

Lisa Anderson, Rozina Bhimani

Rehabilitation Research and Practice, 2014

View PDFchevron_right

A systematic review on extracorporeal shock wave therapy and botulinum toxin for spasticity treatment: a comparison on efficacy

Alina Iliescu

European Journal of Physical and Rehabilitation Medicine

View PDFchevron_right

Changes in body composition after spasticity treatment with intrathecal baclofen

Olle Skogberg

Journal of Rehabilitation Medicine, 2017

View PDFchevron_right

Intrathecal Delivery of Baclofen As Functional Treatment of Severe Spasticity

Katja Sršen

2016

View PDFchevron_right

Clinical use of polysynaptic flexion reflexes in the management of spasticity with intrathecal baclofen

Marc Sindou

Electroencephalography and clinical neurophysiology, 1997

View PDFchevron_right

Spasticity in practice (SPACE): an international non-interventional study of botulinum neurotoxin type A in treatment-naïve subjects with spasticity

Wolfgang Jost

Neurologia i Neurochirurgia Polska, 2021

View PDFchevron_right

Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin

Leland Albright

Journal of Neurosurgery, 2003

View PDFchevron_right

Improvements in healthcare and cost benefits associated with botulinum toxin treatment of spasticity and muscle overactivity

Alberto Esquenazi

European Journal of Neurology, 2006

View PDFchevron_right

Non-pharmacological interventions for spasticity in adults: An overview of systematic reviews

Bhasker Amatya

Annals of physical and rehabilitation medicine, 2018

View PDFchevron_right

Common goal areas in the treatment of upper limb spasticity: A multicentre analysis

Stephen Ashford

Clinical rehabilitation, 2015

View PDFchevron_right

Outcomes of intratechal baclofen (itb) therapy in spacticity

Saim Kazan

Turkish Neurosurgery, 2010

View PDFchevron_right